Key points are not available for this paper at this time.
Design
Editorial
No takes yet. Share an insight, caveat, or question.
This editorial highlights the growing recognition of tricuspid regurgitation as a prognostic marker and therapeutic target, alongside new insights into aortic valve disease and thromboembolism.
Thomas F. Lüscher (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: